5V37
Crystal structure of SMYD3 with SAM and EPZ028862
Summary for 5V37
| Entry DOI | 10.2210/pdb5v37/pdb |
| Related | 5V3H |
| Descriptor | Histone-lysine N-methyltransferase SMYD3, ZINC ION, S-ADENOSYLMETHIONINE, ... (8 entities in total) |
| Functional Keywords | protein-inhibitor complex, protein lysine methyltransferase, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
| Biological source | Homo sapiens (Human) |
| Total number of polymer chains | 1 |
| Total formula weight | 50615.90 |
| Authors | Boriack-Sjodin, P.A. (deposition date: 2017-03-06, release date: 2018-03-07, Last modification date: 2024-03-06) |
| Primary citation | Thomenius, M.J.,Totman, J.,Harvey, D.,Mitchell, L.H.,Riera, T.V.,Cosmopoulos, K.,Grassian, A.R.,Klaus, C.,Foley, M.,Admirand, E.A.,Jahic, H.,Majer, C.,Wigle, T.,Jacques, S.L.,Gureasko, J.,Brach, D.,Lingaraj, T.,West, K.,Smith, S.,Rioux, N.,Waters, N.J.,Tang, C.,Raimondi, A.,Munchhof, M.,Mills, J.E.,Ribich, S.,Porter Scott, M.,Kuntz, K.W.,Janzen, W.P.,Moyer, M.,Smith, J.J.,Chesworth, R.,Copeland, R.A.,Boriack-Sjodin, P.A. Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation. Plos One, 13:e0197372-e0197372, 2018 Cited by PubMed Abstract: A key challenge in the development of precision medicine is defining the phenotypic consequences of pharmacological modulation of specific target macromolecules. To address this issue, a variety of genetic, molecular and chemical tools can be used. All of these approaches can produce misleading results if the specificity of the tools is not well understood and the proper controls are not performed. In this paper we illustrate these general themes by providing detailed studies of small molecule inhibitors of the enzymatic activity of two members of the SMYD branch of the protein lysine methyltransferases, SMYD2 and SMYD3. We show that tool compounds as well as CRISPR/Cas9 fail to reproduce many of the cell proliferation findings associated with SMYD2 and SMYD3 inhibition previously obtained with RNAi based approaches and with early stage chemical probes. PubMed: 29856759DOI: 10.1371/journal.pone.0197372 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.42 Å) |
Structure validation
Download full validation report
